Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First Line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT02453282
What this trial is testing

Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small-Cell Lung Carcinoma NSCLC
AstraZeneca 1,118
Early research (Phase 1)Study completedNCT00621361
What this trial is testing

Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients

Who this might be right for
Lung Cancer
AstraZeneca 62
Large-scale testing (Phase 3)UnknownNCT00465491
What this trial is testing

Study of Picoplatin Efficacy After Relapse

Who this might be right for
Small Cell Lung Cancer
Poniard Pharmaceuticals 399
Testing effectiveness (Phase 2)Study completedNCT05316818
What this trial is testing

Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma

Who this might be right for
Metastatic Colorectal Cancer
Kasr El Aini Hospital 64
Large-scale testing (Phase 3)Ended earlyNCT00418574
What this trial is testing

Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients

Who this might be right for
Ovarian Cancer
Menarini Group 888
Testing effectiveness (Phase 2)Looking for participantsNCT05266846
What this trial is testing

Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK

Who this might be right for
ALK Gene MutationLung AdenocarcinomaImmunotherapy
Hunan Province Tumor Hospital 78
Not applicableStudy completedNCT05261438
What this trial is testing

Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

Who this might be right for
Non-squamous NSCLC
Hunan Province Tumor Hospital 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05796089
What this trial is testing

Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy

Who this might be right for
Extensive-Stage Small-Cell Lung Cancer
Trans Tasman Radiation Oncology Group 35
Testing effectiveness (Phase 2)Study completedNCT05289908
What this trial is testing

Intrathecal Pemetrexed for Leptomeningeal Metastasis

Who this might be right for
Leptomeningeal Metastases
The First Hospital of Jilin University 34
Testing effectiveness (Phase 2)Study completedNCT00629148
What this trial is testing

Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC)

Who this might be right for
Breast CancerMetastasis, Neoplasm
Fudan University 60
Testing effectiveness (Phase 2)Study completedNCT00327535
What this trial is testing

Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.

Who this might be right for
Anemia
Hoffmann-La Roche 153
Testing effectiveness (Phase 2)UnknownNCT04824924
What this trial is testing

Venetoclax in Combination With Low-dose HHT, G-CSF, and AZA as First-line Treatment for Newly Diagnosed Elderly AML Patients Unfit for Intensive Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT06477523
What this trial is testing

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

Who this might be right for
SCLC, Extensive Stage
Sichuan University 57
Testing effectiveness (Phase 2)Study completedNCT01056276
What this trial is testing

Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 59
Large-scale testing (Phase 3)Looking for participantsNCT05973786
What this trial is testing

The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

Who this might be right for
Bipolar Depression
Dr. Inge Winter 418
Testing effectiveness (Phase 2)Ended earlyNCT00701870
What this trial is testing

Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Telik 1
Testing effectiveness (Phase 2)UnknownNCT03410368
What this trial is testing

NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer.

Who this might be right for
Small Cell Lung Cancer
jiuwei cui 120
Testing effectiveness (Phase 2)Ended earlyNCT04933227
What this trial is testing

Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ)

Who this might be right for
Stomach NeoplasmsGastric CancerGastroesophageal Junction Adenocarcinoma
Hoffmann-La Roche 29
Testing effectiveness (Phase 2)UnknownNCT04698941
What this trial is testing

Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07251062
What this trial is testing

SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.

Who this might be right for
Esophageal Squamous Cell Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd. 737
Next Page